600161.SS
600161.SS
CNE000000WF9
BEIJING TIANTAN BIOLOGICAL PROD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 6.168.036.315 6.031.865.460
2.3%
Cost of Revenue 3.463.231.713 2.732.440.126
26.7%
Gross Profit 2.704.804.602 3.299.425.335
18.0%
812.333.152 778.159.390
4.4%
Operating Income 1.892.471.450 2.521.265.944
24.9%
Pretax Income 1.822.723.792 2.547.217.503
28.4%
Net Income Common Stockholders 1.090.837.981 1.549.164.832
29.6%
-- --
--
-- --
--
ende